Pitavastatin-loaded procyanidins self-assembled nanoparticles alleviate advanced atherosclerosis via modulating macrophage efferocytosis and cholesterol efflux
Acta Pharmaceutica Sinica B · 2025-06 · 15 (6) · 3305-3320
DOI: 10.1016/j.apsb.2024.08.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-06. Verfasst von Yizhou Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Biology, Hunan University, Changsha 410082, China. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Advanced atherosclerosis is the major global cause of death, as featured by the aggregation of apoptotic cells (ACs) in necrotic cores. The defective efferocytosis and dysfunctional cholesterol efflux of macrophages are the main reasons for forming necrotic cores in advanced atherosclerosis. In this study, we constructed self-assembled procyanidins (PC) NPs for loading pitavastatin (Pita). The designed HA@PC@Pita NPs with hyaluronic acid (HA) modification combined the advantages of efferocytosis restoration of Pita and cholesterol efflux enhancement of PC. In vitro assay indicated that HA@PC@Pita NPs could induce M1/M2 repolarization and upregulate ERK5/Mertk expression to restore efferocytosis of macrophages. Simultaneously, HA@PC@Pita NPs notably promoted cholesterol efflux by promoting macrophage lipophagy, a selective autophagy of lipid droplets. In vivo study showed that HA@PC@Pita NPs cleared necrotic core and enhanced plaque stability in the ApoE -/- mice model with advanced atherosclerosis. Taken together, this study demonstrated the potential of HA@PC@Pita NPs for the treatment of advanced atherosclerosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Biology, Hunan University, Changsha 410082, China.
- Precision Pharmacy & Drug Development Center, Department of Pharmacy, Second Affiliated Hospital, Air Force Medical University, Xi'an 710038, China.
- Department of Rehabilitation, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
- NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China.
- Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou 646000…
Förderung
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Wu, Y., Zhou, H., Liu, H., Hu, J., Sun, Y., Yan, W., Tong, C., Kong, Y., & Liu, B. (2025). Pitavastatin-loaded procyanidins self-assembled nanoparticles alleviate advanced atherosclerosis via modulating macrophage efferocytosis and cholesterol efflux. Acta Pharmaceutica Sinica B, 15(6), 3305-3320. https://doi.org/10.1016/j.apsb.2024.08.006
Vancouver
Wu Y, Zhou H, Liu H, Hu J, Sun Y, Yan W, et al. Pitavastatin-loaded procyanidins self-assembled nanoparticles alleviate advanced atherosclerosis via modulating macrophage efferocytosis and cholesterol efflux. Acta Pharmaceutica Sinica B. 2025;15(6):3305-3320. doi:10.1016/j.apsb.2024.08.006
BibTeX
@article{Wu2025,
author = {Wu, Yizhou and Zhou, Hongyan and Liu, Hao and Hu, Jiayao and Sun, Yue and Yan, Wei and Tong, Chunyi and Kong, Ying and Liu, Bin},
title = {Pitavastatin-loaded procyanidins self-assembled nanoparticles alleviate advanced atherosclerosis via modulating macrophage efferocytosis and cholesterol efflux},
journal = {Acta Pharmaceutica Sinica B},
year = {2025},
volume = {15},
number = {6},
pages = {3305--3320},
doi = {10.1016/j.apsb.2024.08.006}
}
EUVIMED